Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colonic Neoplasms 3Urinary Bladder Neoplasms 2Pain 2Breakthrough Cancer Pain 2Agnosia 2Rectal Neoplasms 1Postoperative Cognitive Complications 1Pleural Effusion, Malignant 1Pleural Effusion 1Pleural Diseases 1Pain, Postoperative 1Neoplasms 1Nasopharyngeal Carcinoma 1Intrathecal Dexmedetomidine 1Ileus 1Head and Neck Neoplasms 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1

Interventions

Cisplatin 51Gemcitabine 24Radiotherapy, Intensity-Modulated 21Docetaxel 20Fluorouracil 15camrelizumab 12Drug Therapy 11Radiotherapy 10toripalimab 8Chemoradiotherapy 8Capecitabine 8apatinib 7Induction Chemotherapy 7nimotuzumab 6endostar protein 6Endostatins 6sintilimab 5nedaplatin 5Bevacizumab 5fludarabine 4Cyclophosphamide 4spartalizumab 3fludarabine phosphate 3cisplatin-guanosine adduct 3SSRP1 protein, human 3Paclitaxel 3Injections 3Endoscopy 3tislelizumab 2Vitamin B 12 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Carcinoma × Fentanyl × Clear all
NCT04292990 2020-07-29

Comparison of Transdermal Fentanyl and Morphine for Oral Mucositis Pain in Nasopharyngeal Cancer Patients

Jiangmen Central Hospital

Phase 4 Unknown
300 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡